Skip to main content
. 2020 Dec 9;10:578963. doi: 10.3389/fonc.2020.578963

Figure 4.

Figure 4

Low METTL14 and ZC3H13 expression demonstrates poor prognosis in breast cancer. (A–D) Prognostic significance of METTL14 and ZC3H13 gene expression in breast cancer patients based on the Kaplan–Meier plotter database. RFS, relapse-free survival; OS, overall survival. (E, F) The RFS curves of METTL14 and ZC3H13 gene expression in four types breast cancer patients, including luminal type A, luminal type B, HER2 enriched type, and triple negative type (TNBC).